Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Dec 5:7:222.
doi: 10.3389/fneur.2016.00222. eCollection 2016.

Commentary: Tumefactive Demyelinating Lesions as a First Clinical Event: Clinical, Imaging, and Follow-up Observations

Tatiana Koudriavtseva  1 , Domenico Plantone  1
Affiliations
Comment

Commentary: Tumefactive Demyelinating Lesions as a First Clinical Event: Clinical, Imaging, and Follow-up Observations

Tatiana Koudriavtseva et al. Front Neurol. .
No abstract available

Keywords: MRI; multiple sclerosis; susceptibility-weighted imaging; tumefactive demyelinating lesions; venous vasculature.

PubMed Disclaimer

Comment on

References

    1. Jeong IH, Kim S-H, Hyun J-W, Joung A, Cho H-J, Kim HJ. Tumefactive demyelinating lesions as a first clinical event: clinical, imaging, and follow-up observations. J Neurol Sci (2015) 358:118–24.10.1016/j.jns.2015.08.034 - DOI - PubMed
    1. Siri A, Carra-Dalliere C, Ayrignac X, Pelletier J, Audoin B, Pittion-Vouyovitch S, et al. Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study. J Neurol (2015) 262:1637–45.10.1007/s00415-015-7758-8 - DOI - PubMed
    1. Blasel S, Pfeilschifter W, Jansen V, Mueller K, Zanella F, Hattingen E. Metabolism and regional cerebral blood volume in autoimmune inflammatory demyelinating lesions mimicking malignant gliomas. J Neurol (2010) 258:113–22.10.1007/s00415-010-5703-4 - DOI - PubMed
    1. Kiriyama T, Kataoka H, Taoka T, Tonomura Y, Terashima M, Morikawa M, et al. Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm. J Neuroimaging (2011) 21:e69–77.10.1111/j.1552-6569.2010.00502.x - DOI - PubMed
    1. Lucchinetti CF, Gavrilova RH, Metz I, Parisi JE, Scheithauer BW, Weigand S, et al. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain (2008) 131:1759–75.10.1093/brain/awn098 - DOI - PMC - PubMed

LinkOut - more resources